Profil bibliographique

Mako Miwa

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

3Publications signalées
3Citations signalées
2Affiliations récentes

Les institutions déclarées

St. Luke's International HospitalNational Center of Neurology and Psychiatry

Les domaines associés

Schizophrenia research and treatmentTryptophan and brain disordersHealthcare Decision-Making and RestraintsMental Health and PsychiatryAlcoholism and Thiamine Deficiency

Les publications récentes

Accès ouvert 2025 article OpenAlex

A case of Poirier-Bienvenu neurodevelopmental syndrome with non-epileptic seizures, phonophobia, and autism spectrum disorder

Mako Miwa, Mina Yokoyama, Rintaro Ono, Miwa Ozawa et autres

Poirier-Bienvenu neurodevelopmental syndrome (POBINDS) is caused by mutations in CSNK2B and is characterized by intellectual disability (ID) and early-onset epilepsy. The patient was delivered at term with no perinatal complications. Although early development was typical, delayed walking prompted a referral. Various screening …

jp (code pays fourni par la source)

0 citations Brain and Development Case Reports
Accès ouvert 2025 conference-abstract OpenAlex

VALUABLE INTERACTION WITH COGNITIVE REMEDIATION AND OPTIMAL ANTIPSYCHOTICS FOR RECOVERY IN SCHIZOPHRENIA (VICTORY-S): STUDY PROTOCOL FOR AN INTERVENTIONAL, OPEN-LABEL, RATER- BLINDED, RANDOMIZED COMPARISON OF COMBINED TREATMENT WITH COGNITIVE REMEDIATION AND LURASIDONE OR PALIPERIDONE

Ryotaro Kubota, Satoru Ikezawa, Hideki Oi, Mari S. Oba et autres

Abstract Background Cognitive impairment, a core feature of schizophrenia, is associated with poor functional outcomes. Available interventions include both pharmacotherapy and psychosocial treatment. However, each of these interventions, when used alone, have often inadequate effect sizes. Aims & Objectives This study aims …

jp (code pays fourni par la source)

0 citations The International Journal of Neuropsychopharmacology
Accès ouvert 2024 article OpenAlex

Valuable interaction with cognitive remediation and optimal antipsychotics for recovery in schizophrenia (VICTORY-S): study protocol for an interventional, open-label, randomized comparison of combined treatment with cognitive remediation and lurasidone or paliperidone

Ryotaro Kubota, Satoru Ikezawa, Hideki Oi, Mari S. Oba et autres

Background: Cognitive impairment, a core feature of schizophrenia, is associated with poor outcomes. Pharmacotherapy and psychosocial treatment, when used alone, have inadequate effect sizes for cognitive impairment, leading to recent interest in combination interventions. A previous study examined the additive effect of …

jp (code pays fourni par la source)

3 citations Frontiers in Psychiatry
Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.